Chromic acid degradation of a d-urobilin, obtained after incubation of bilirubin in fecal bacterial cultures, gave methylvinylmaleimide and methylethylmaleimide. The d-urobilin, molecular weight 588, C331740-N406, clearly showed the presence of both vinyl and ethyl resonances in the nuclear magnetic resonance spectrum. These results point unambiguously to a urobilin structure with one vinyl and one ethyl beta-substituent.
N406, clearly showed the presence of both vinyl and ethyl resonances in the nuclear magnetic resonance spectrum. These results point unambiguously to a urobilin structure with one vinyl and one ethyl beta-substituent.
The earlier history of the urobilinoids, including the d-urobilins, has recently been reviewed (1) . A d-urobilin was first obtained in crystalline form by Schwartz and Watson (2) in 1942 from infected human bile. A d-urobilin was also later found by Sborov and Schwartz in dog feces (3) and by Sborov and coworkers (4) in the feces of patients receiving tetracycline. Combustion analyses (5, 6) could not distinguish between CuH4oN406 and CuH42N406 for the urobilin, or Cr H42N406 and C3gH44N406 for the chromogen. An H40 urobilin would be consonant with a monovinyl (beta-substituent) compound, whereas H42 would agree with a diethyl urobilin. Later, Gray and Nicholson (7) isolated a considerable amount of a d-urobilin from the feces of a patient with hemolytic anemia due to thalassemia major and who had not received antibiotics. A detailed examination of this sample, including the observation that it consumed an extra mole of hydrogen on catalytic hydrogenation, led them to favor a d-urobilin (H4o) with one vinyl beta-substituent. However, as they noted, the data did not unambiguously exclude a structure having an extra unsaturation in an end ring, a formulation suggested earlier by Siedel (8) .
Since these earlier observations, d-urobilins have often been isolated either from human feces or fecal bacterial cultures (9, 10) . Their molecular weights, occasionally 588 (H40) or more often 590 (H42), were determined by mass spectrometry (9) . A d-urobilin (H40) has been produced on three occasions in separate cultures of human fecal flora with bilirubin, but not with mesobilirubin, as substrate (9, 10) , and has also been isolated repeatedly from samples of dog feces (9, 10) . It is of interest to note that a human strain of Clostridium perfringens isolated from ileostomy feces reduced bilirubin to a d-urobilin (H42) (11) with either bilirubin or mesobilirubin as substrate, whereas a rat Clostridium species (12) has invariably produced I-stercobilin or i-half stercobilin, in vitro (10) .
Very recently Killilea and O'Carra (13) challenged the existence of an H40 d-urobilin by disputing, inter alia, the interpretation of the mass spectral data in the molecular ion region. They invoked the already described disproportionation of l-stercobilin before volatilization in the ionization chamber of the mass spectrometer (9) . When heated near its melting point, l-stercobilin (molecular weight, mol. wt. 594) apparently undergoes an oxidation and reduction reaction to yield volatile substances with molecular ions at m/e (mass to charge ratio) 592 and 596 with a standard electron impact source. Killilea and O'Carra explain the appearance of m/e 588 in the mass spectrum of d-urobilins in terms of disproportionation of an H42 d-urobilin (mol. wt. 590). This apparently reasonable explanation is possibly flawed by the observation (9) that d-urobilin samples which show ions in the mass spectrometer at m/e 588 and 590 seldom show much intensity at m/e 592. When stercobilin (mol. wt. 594) undergoes disproportionation, it exhibits an early and relatively intense peak at m/e 596. The parallel behavior for an H42 durobilin (mol. wt. 590) would be the appearance of an early intense peak at m/e 592. However, such a peak is not observed.
In the present work, we present conclusive evidence for the existence of an H40 d-urobilin (mol. wt. 588) with one vinyl beta-substituent. The data are provided by chromic acid oxidation analysis, and nuclear magnetic resonance (NMR) spectroscopy.
MATERIAL AND METHODS
d-Urobilin (m/e 588 as mol. wt.) was obtained from the fecal bacterial reduction of bilirubin IXa in vitro (10) . The bilirubin IXa used in these experiments was purchased from Nutritional Biochemicals Corporation. NMR spectra were determined on a Varian XL-100 spectrometer equipped with rapid pulse Fourier analysis capabilities, or on a Varian 300 MHz instrument in the continuous wave mode. The bilirubin used in these studies was purchased from Sigma. Mass spectra were measured on a Varian MAT 311 spectrometer at 70 eV. The chromic acid oxidations were carried out according to Rudiger's method (14) . RESULTS 
AND DISCUSSION
The nuclear magnetic resonance data A careful examination of the NMR spectrum should reveal whether a d-urobilin (588) possesses a vinyl beta-substituent Abbreviations: mol. wt., molecular weight; m/e, mass to charge ratio; DMSO-d6, completely deuterated dimethyl sulfoxide; NMR, nuclear magnetic resonance.
Chemistry: Chedekel et al. Hence, the 100 and 300 MHz NMR spectra of bilirubin IXa (la, vinyl groups at C-2 and C-8) were determined (Figs. 1-3 ). This was done as follows. The bilirubin spectrum ( Fig. 1) was compared with the spectrum of mesobilirubin IXa (lb), which has ethyl instead of the vinyl groups at C-2 and C-8.
The set of resonances between 5 and 75 (ppm, tetramethylsilane) in the bilirubin spectrum were not present in the mesobilirubin spectrum. Therefore that region was assigned to the vinyl groups at C-2 and C-8 of bilirubin, and it agrees in location with the well-established assignments for the vinyl resonances of butadiene and styrene (Table 1 ). In the case of bilirubin, the vinyl resonances in the expanded vinyl region of Fig. 2 (100 MHz) were more completely resolved into two ABC patterns by going to 300 MHz ( Fig. 3 and Table 1 
